Panacea Life Sciences Holdings, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2013 | — | $193.7K | $35.5K |
| Jun 2014 | — | — | $101.3K |
| Sep 2014 | — | — | $86.2K |
| Dec 2014 | — | $45.8K | $41.7K |
| Mar 2015 | — | — | $37.9K |
| Jun 2015 | — | $-2.0K | $32.6K |
| Sep 2015 | — | $-66.0K | $11.7K |
| Dec 2015 | — | $-93.3K | $0 |
| Mar 2016 | — | $143.2K | $227.1K |
| Jun 2016 | — | $882.3K | $38.8K |
| Sep 2016 | — | $647.5K | $34.5K |
| Dec 2016 | $0 | $1.5M | $1.1M |
| Mar 2017 | — | $924.0K | $296.9K |
| Jun 2017 | — | $417.7K | $18.1K |
| Sep 2017 | — | $-300.1K | $33.0K |
| Dec 2017 | $57.8K | $-2.2M | $161.2K |
| Mar 2018 | — | $-2.4M | $38.9K |
| Jun 2018 | — | $-2.9M | $54.0K |
| Sep 2018 | — | $-4.1M | $1.3K |
| Dec 2018 | $591.8K | $-3.4M | $2.0K |
| Mar 2019 | $100.0K | $2.6M | $1.2M |
| Jun 2019 | $100.0K | $4.4M | $664.6K |
| Sep 2019 | $100.0K | $7.8M | $5.7K |
| Dec 2019 | $185.9K | $11.9M | $18.4K |
| Mar 2020 | $402.2K | $9.9M | $9.5K |
| Jun 2020 | $335.5K | $10.6M | $298.8K |
| Sep 2020 | $335.5K | $6.8M | $59.1K |
| Dec 2020 | $335.5K | $6.7M | $84.4K |
| Mar 2021 | — | $7.1M | $19.7K |
| Jun 2021 | — | $11.5M | $130.7K |
| Sep 2021 | — | $8.4M | $14.5K |
| Dec 2021 | — | $7.1M | $19.8K |
| Mar 2022 | — | $4.2M | $56.0K |
| Jun 2022 | — | $2.3M | $36.5K |
| Sep 2022 | — | $-439.9K | $36.8K |
| Dec 2022 | — | $-2.1M | $7.0K |
| Mar 2023 | — | $-3.8M | $73.2K |
| Jun 2023 | — | $-5.6M | $8.2K |
| Sep 2023 | — | $-6.1M | $1.5K |
| Dec 2023 | — | $-8.3M | $100.9K |
| Mar 2024 | — | $-9.6M | $107.6K |